Skip to main content

Evaluate Efficacy and Safety of CC-90001 in Subjects with Idiopathic Pulmonary Fibrosis

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Celgene Corporation

Start Date

December 19, 2017

End Date

June 14, 2024
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Celgene Corporation

Start Date

December 19, 2017

End Date

June 14, 2024